Expert Speakers | 8th Neuropsychiatric Drug Development

Expert Speaker Faculty

Aaron Koenig

Chief Medical Officer

Delix Therapeutics

Abhi Pratap

Executive Director, Global Evidence Lead

Boehringer Ingelheim

Alastair Brown

Senior Vice President, Translational Medicine

Nxera Pharma

Alex Goddard

Director, McQuade Center for Strategic Research and Development

Otsuka

Amir Inamdar

Chief Medical Officer

Cybin

Amy Kruse

Chief Investment Officer

Satori Capital

Chris Weyrer

Principal

Vida Ventures

Colin Sauder

Chief Scientific Officer

Adams Clinical (formerly Bristol Myers Squibb / Karuna Therapeutics)

Dan Bonner

Co-Founder & Senior Vice President, Platform

Seaport Therapeutics

David Olson

Chief Innovation Officer

Delix Therapeutics

Drew Elias

Director, Global Regulatory Lead, Neuroscience

Johnson & Johnson

Heramb Chadchankar

Heramb Chadchankar

Senior Director & Head of Translational Science

Kynexis Therapeutics

Jackie von Salm

Jackie von Salm

Co-Founder & Chief Scientific Officer

Psilera

Jacob Jacobsen

Chief Executive Officer

Evecxia Therapeutics

James Cronican

Head of Translational Medicine & Clinical Pharmacology for Neuroscience & Mental Health

Boehringer Ingelheim

James Gilligan

President & Chief Executive Officer

Tryp Therapeutics

Jamileh Jemison

Jamileh Jemison

Medical Director, Clinical Development

MindMed

Janet Nicholson

Janet Nicholson

Global Asset Lead, CNS Diseases, Translational Medicine

Boehringer Ingelheim

Jessica Ash

Director of Digital Health, R&D

Otsuka

Johan Luthman

Executive Vice President & Head of R&D

Lundbeck

Kevin Spencer

Associate Professor of Psychiatry

Harvard University

Krishna Vadodaria

Krishna Vadodaria

Director

Engrail Therapeutics

Liam Scott

Senior Director, Translational Sciences

Neumora

Mark Pollack

Chief Medical Officer

Reunion Neuroscience

Matt Harlin

Senior Director, Discovery Research, Early Phase & Translational Medicine

Otsuka

Matthew Johnson

Matthew Johnson

Senior Group Leader

The Broad Institute of MIT & Harvard

Matthew Kuntz

Vice President, Global Regulatory Affairs, Neuroscience

Abbvie

Michael Bowen

Chief Scientific Officer

Kinoxis Therapeutics

Nanco Hefting

Chief Scientific Specialist

Lundbeck

Natalie Sacks

Venture Partner

Novo Holdings

Nurulain Zaveri

Nurulain Zaveri

President & Chief Scientific Officer

Astraea Therapeutics

Odette Hauke

Regulatory Affairs Consultant

Independent

Sam Benezra

Senior Scientist, Neural Circuits Group

Biogen

Silke Miller

Distinguished Scientist, Translational Sciences

Johnson & Johnson

Snezana Milanovic

Snezana Milanovic

Senior Director, Clinical Development

Neumora

Steve Brannan

Former Chief Medical Officer

Karuna Therapeutics

Steve Levine

Chief Patient Officer

Compass Pathways

Steven Hyman

Professor of Stem Cell & Regenerative Biology

Harvard University

Suresh Durgam

Chief Medical Officer, Executive Vice President

Intra-Cellular Therapies

Trent Fowler

Associate Director, Bioanlaysis, Genomics & Biomarker Research Early Phase Translational Medicine

Otsuka

William Horan

Clinical Science Program Lead, Neuropsychiatry

Bristol Myers Squibb

Zhanyan Fu

Associate Director

Broad Institute of MIT & Harvard